FULLY FUNDED TERTIARY QUALIFICATION LAUNCHES TO ADDRESS PERINATAL MENTAL HEALTH CLINICIAN SHORTAGE IN AUSTRALIAN-FIRST Tertiary qualification launched by Gidget Foundation and Federation University.
With Arabella Gibson, CEO
Gidget Foundation Australia
SEGMENT
Filmed in North Sydney | January 2025
Demand for perinatal mental health services is continuing to surge year-on-year. In fact, perinatal mental health organisation, Gidget Foundation Australia (GFA), has supported 30% more clients in FY2024 than in FY2023, up by 214% since FY2021.
Perinatal depression and anxiety (PNDA) impacts 100,000 Australians each year, equating to one in five mums and one in ten dads, with PNDA costing Australia $877 million annually. To address the nationwide shortage of specialist perinatal mental health clinicians, Gidget Foundation Australia has partnered with Federation University to launch the Graduate Diploma in Perinatal Mental Health.
Australian Health Journal met with Arabella Gibson, CEO Gidget Foundation Australia following the announcement to hear about the Gidget mission and the new initiative to address the perinatal mental health clinician shortage.
The new Graduate Diploma in Perinatal Mental Health creates a unique offering in the industry, providing comprehensive ‘on the job’ training, weekly supervision for clinicians, academic modules and a paid placement opportunity as well as ongoing employment through Gidget Foundation Australia’s face-to-face or telehealth services.
The new partnership, create an Australian-first offering of a fully supported tertiary qualification. Gidget Foundation Australia and Federation University have engaged in the unique co-design and co-delivery of the qualification, with both organisations developing and delivering practical and theoretical course content.
Ms Gibson says the Gidget Foundation, with Federation University, is committed to ensuring robust clinical standards are achieved through providing exceptional education for clinicians working in the perinatal space.
“We’ve seen demand for perinatal depression and anxiety support continue to rise, our clinicians supported 30% more clients in FY2024 than in FY2023. It’s essential we have enough qualified clinicians to meet this growing demand to address the critical needs of the individuals impacted.
“Equity, access, and affordability can be a barrier for allied health professionals to further extend their professional knowledge and skills. The Graduate Diploma in Perinatal Mental Health enables health professionals to upskill in perinatal and infant mental health and creates an accessible pathway to enhance knowledge and experience across the sector; whilst benefitting the health professional, clients, and the wider community.”, says Ms Gibson.
The first cohort of the new Graduate Diploma in Perinatal Mental Health will graduate in July 2025 and applications opened in November 2024 for the February 2025 intake.
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.
-
Lasers in dental treatment without needles and drills
In 2017, Dr. Omar Zuaiter and Alaa Habeb launched Dentroid, a dental technology startup with a mission to make dentistry a kinder and friendlier experience for patients and dentists using photonics (using laser technology) and robotics, as alternatives to needles, drills and sprays. The vision for the startup is to have dentistry adopt laser technology, addressing the root causes of dental pain & anxiety, and create a pain-free dental experience.
